CDKN2B-AS1 and cancer: Genome-wide association studies have identified SNPs in CDKN2BAS associated with susceptibility to NST as well as to melanoma [22,23]; interestingly, CDKN2BAS has been identified as a risk locus also for other cancers and diseases [24].